StonvexLoading…
StonvexStonvexStonvexCore line items from MYND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $267.38M | $411.76M | $584.68M | $448.19M |
Operating Income | $-38.04M | $-46.04M | $3.43M | $11.07M |
Net Income | $-95.72M | $-39.43M | $20.46M | $-1.10M |
EPS (Diluted) | $-0.21 | $-0.09 | $0.05 | $0.00 |
Total Assets | $252.62M | $407.04M | $368.78M | $283.08M |
Total Liabilities | $224.25M | $286.44M | $231.77M | $203.92M |
Cash & Equivalents | $75.32M | $87.80M | $29.31M | $33.32M |
Free Cash Flow OCF − CapEx | $-497.00K | $-2.75M | $-6.10M | $-23.10M |
Shares Outstanding | 454.96M | 456.48M | 426.42M | 28.04M |